Harnessing Artificial Intelligence to Save Lives: Early Detection of Cervical Cancer in Mozambique
Cervical cancer remains the leading cause of cancer-related deaths among women in Mozambique, with thousands of new cases every year, particularly in rural areas where access to specialized medical services is extremely limited. Early diagnosis is often impossible, and as a result, many women only receive medical attention when the disease is already at an advanced stage.
To address this urgent challenge, MozBioMed.AI, in strategic partnership with the Hospital Central de Nampula and a network of national and international medical experts, is developing four mobile Artificial Intelligence (AI) applications designed to provide early, automated, and accessible detection of cervical cancer.
These innovative tools are being designed for use by non-specialist healthcare professionals, including nurses and general practitioners working in remote areas — enabling them to conduct fast and reliable screenings with nothing more than a mobile phone or tablet. By decentralizing access to diagnostic support, this project aims to bring oncology services beyond urban centres and closer to the women who need them most.
Key Highlights
- AI-driven innovation: mobile applications trained on medical images and clinical data.
- Accessibility & affordability: usable on standard smartphones and tablets, with low implementation cost.
- Decentralized healthcare: empowering rural clinics and health posts to provide early cancer detection.
- Direct social impact: saving lives by ensuring more women are diagnosed and treated in early stages.
- Capacity building: training local healthcare providers to use and maintain the technology.
Strategic Partnership
- This initiative is led by MozBioMed.AI with the active collaboration of the Hospital Central de Nampula (Mozambique), represented by a multidisciplinary group of Mozambican medical specialists, alongside international researchers committed to advancing digital health solutions in low-resource settings.
Expected Impact
By bridging cutting-edge AI technology with urgent public health needs, this project has the potential to significantly reduce mortality from cervical cancer in Mozambique, while setting a precedent for similar digital health solutions across Sub-Saharan Africa. It represents a step towards an inclusive and equitable digital medicine, where every woman regardless of where she lives has access to timely diagnosis, hope, and dignity in healthcare.
Contact
- 17 Longford Place, Manchester, England, M14 5QQ
- +44 7936 386026
- contact@mozbiomed.co.uk
